Pulse ·
WHO dementia prevention overhaul: drop the supplements, move more
The WHO has updated its dementia prevention guidelines for the first time in seven years. Vitamin B, E, omega-3, and multivitamins are now strongly recommended against for brain protection — the trials have not shown benefit. Physical activity is now the strongest evidence-backed modifiable intervention for people with normal cognition. Menopausal hormone therapy is not recommended for cognitive decline prevention in women aged 65 and over, though it remains appropriate for other indications at GP discretion. Managing blood pressure, cholesterol, glucose, weight, and hearing remains the key prevention foundation.
What just happened
The World Health Organization has released its first comprehensive dementia prevention update in seven years — and if you have been taking vitamin supplements for your brain, the findings are unambiguous.
A suite of supplements that millions of people take specifically for cognitive protection — vitamin B, vitamin E, omega-3 fatty acids, and multivitamin-mineral combinations — now carry a strong WHO recommendation against their use for dementia prevention. The evidence, once considered promising, has not held up at population scale.
In their place: physical activity now carries an elevated strong recommendation as the most evidence-backed modifiable intervention for reducing dementia risk in adults with normal cognition. Cognitive stimulation — structured programmes, reading, storytelling — joins the recommended toolkit for those already experiencing mild cognitive impairment.
If you are one of the many Australians who has been quietly taking fish oil or vitamin B for your brain, this update is directly relevant.
The both-and
What changed, and why it matters
Dementia is Australia’s second leading cause of death and the leading cause of disability in older Australians. With the number of Australians living with dementia expected to more than double by 2058, the clinical and economic case for effective prevention is substantial. These guidelines shape what GPs worldwide will be recommending.
The update’s core messages:
Supplements are out for brain protection. The WHO’s language is direct — not “insufficient evidence” but a specific strong recommendation against using vitamin B, vitamin E, omega-3, and multivitamins for the purpose of preventing cognitive decline. The trials have been conducted, and they have not shown benefit. Taking these products specifically for dementia prevention is no longer an evidence-based choice.
Physical activity is in, more strongly than before. Previous WHO guidance mentioned physical activity as useful; the updated guidelines elevate it to a strong recommendation with moderate evidence certainty. The mechanism is well understood: physical activity improves cardiovascular health, sleep quality, and mood, and has direct neurobiological effects — including stimulating brain-derived neurotrophic factor and supporting hippocampal volume.
Cardiovascular risk management remains foundational. The guidelines reaffirm that controlling blood pressure, cholesterol, blood glucose, body weight, hearing loss, and managing conditions including diabetes and HIV are among the most impactful things a person can do for long-term brain health. Dementia Australia consistently highlights modifiable cardiovascular risk factors as a central prevention lever — and these guidelines reinforce that position.
Environmental health enters the frame. Reduced exposure to household and ambient air pollution has been added to the prevention evidence base — a recognition that air quality is a modifiable brain health variable, not only a lung health one.
The menopausal hormone therapy question
The WHO update includes a recommendation that menopausal hormone therapy (MHT) should not be used specifically for the purpose of preventing cognitive decline in women aged 65 and over.
This is not the same as saying MHT harms the brain. The evidence for MHT as a cognitive protector is complicated by a well-documented “critical window” hypothesis: oestrogen therapy initiated early in the perimenopause transition may have some neuroprotective effect, while therapy initiated years after menopause — at age 65 or beyond — appears not to benefit cognition and may carry some risk. The WHO recommendation speaks to the latter scenario only.
If you are in perimenopause and considering MHT for vasomotor symptoms, sleep disruption, or quality of life, this guideline does not close that conversation. That is a distinct clinical question with a different evidence base.
What the experts are saying
Professor Kaarin Anstey, one of Australia’s leading dementia researchers, noted that the guidelines will only be effective if they are supported by governments and public health systems. The advice is only as useful as the infrastructure that delivers it — access to safe walking environments, affordable community exercise programmes, and GPs with sufficient consultation time to have these prevention conversations routinely.
That structural point matters. Individual behaviour change is substantially harder in environments that do not support it. Dementia prevention is partly a personal project and partly a public health one.
My two cents
If you have been taking fish oil for your brain, you can save the money. The WHO has moved from “insufficient data” to “strong recommendation against” — a meaningful shift in the evidence consensus, not a minor revision.
What that money might be better spent on: a gym membership, swimming fees, or shoes comfortable enough for a daily walk. Physical activity is now the single most evidence-supported thing you can do for long-term cognitive health. The dose that matters is regular aerobic movement; a specific protocol is less important than consistency.
The cardiovascular risk management message is the less glamorous one but probably the more consequential one. Elevated blood pressure and unmanaged hearing loss, in particular, carry outsize effects on long-term dementia risk. If you have not had your blood pressure checked recently, or have been noticing changes in your hearing without acting on them, those warrant a GP visit that goes beyond the immediate symptom.
Verdict: yes — worth knowing about.
Sources cited
- Vitamins out, physical activity in: new WHO dementia recommendations. The Medical Republic, 20 July 2026. https://www.medicalrepublic.com.au/vitamins-out-physical-activity-in-new-who-dementia-recommendations/127453
- Dementia Australia — About dementia. https://www.dementia.org.au/information/about-dementia
- AIHW — Dementia in Australia. https://www.aihw.gov.au/reports/dementia/dementia-in-australia
Frequently asked questions
-
Should I stop taking fish oil for my brain?
According to the new WHO guidelines, omega-3 supplements — including fish oil — do not reduce the risk of dementia or cognitive decline in people with normal brain function, and the WHO now makes a strong recommendation against using them for this purpose. If you are taking fish oil for another reason (such as cardiovascular health or joint symptoms), that is a separate conversation with your GP. But if the reason was cognitive protection, the evidence no longer supports it for that purpose.
-
Does this mean menopausal hormone therapy is bad for the brain?
No. The WHO recommendation is specifically that menopausal hormone therapy should not be used for the purpose of preventing cognitive decline in women aged 65 and over. It is not a statement that MHT causes cognitive harm. Women using MHT for vasomotor symptoms, sleep, mood, or quality of life during perimenopause and early menopause are in a different clinical category. This is a nuanced area; your GP is the right person to discuss whether MHT is appropriate for your situation and at what stage.